Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus propofol for sedation during gastrointestinal endoscopy in elderly patients
ChiCTR2000039334Phase 4Not yet recruiting
- Sponsor
- Anesthesiology Dept. The Eighth Affiliated Hospital of Sun Yat-Sen University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam and propofol in gastrointestinal conditions (2 arms), sponsored by Anesthesiology Dept. The Eighth Affiliated Hospital of Sun Yat-Sen University. Primary endpoint: Sedation success rate. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2000039334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039334.